ALLOGENE THERAPEUTICS INC's ticker is and the CUSIP is 019770956. A total of 4 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 200 | -99.9% | 0.00% | -100.0% |
| Q1 2023 | $666 | +16550.0% | 134,900 | +19171.4% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 700 | -94.2% | 0.00% | – |
| Q3 2022 | $129,000 | +3125.0% | 12,000 | +2900.0% | 0.00% | – |
| Q2 2022 | $4,000 | -66.7% | 400 | -71.4% | 0.00% | – |
| Q1 2022 | $12,000 | -58.6% | 1,400 | -30.0% | 0.00% | – |
| Q4 2021 | $29,000 | -86.6% | 2,000 | -75.6% | 0.00% | – |
| Q3 2021 | $217,000 | +1.9% | 8,200 | 0.0% | 0.00% | – |
| Q2 2021 | $213,000 | +660.7% | 8,200 | +102400.0% | 0.00% | – |
| Q1 2021 | $28,000 | +64.7% | 8 | +14.3% | 0.00% | – |
| Q4 2020 | $17,000 | +466.7% | 7 | +600.0% | 0.00% | – |
| Q3 2020 | $3,000 | -99.1% | 1 | -98.7% | 0.00% | -100.0% |
| Q2 2020 | $333,000 | +494.6% | 78 | +169.0% | 0.00% | – |
| Q1 2020 | $56,000 | -89.8% | 29 | -86.3% | 0.00% | -100.0% |
| Q4 2019 | $548,000 | +515.7% | 211 | +539.4% | 0.00% | – |
| Q3 2019 | $89,000 | +67.9% | 33 | +65.0% | 0.00% | – |
| Q2 2019 | $53,000 | -93.6% | 20 | -93.0% | 0.00% | -100.0% |
| Q1 2019 | $823,000 | +5043.8% | 285 | +4650.0% | 0.00% | – |
| Q4 2018 | $16,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 40,000 | $197,600 | 0.00% |
| SIMPLEX TRADING, LLC | 134,900 | $666 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 16,700 | $82,498 | 0.00% |